Nov 29, 2022Bioengineering company brings on ag tech expert
Renaissance BioScience Corp., a leader in bioengineering for the global agriculture and food industries, has retained S. Brad Griffith to assist it in commercializing its RNA production and oral delivery platform technology applications for agricultural crop protection, non-agriculture biocontrol and animal health.
Griffith has more than 30 years’ experience in the agriculture industry and life sciences, much of it at a senior executive level, including leading the global commercial BioAg Alliance, a joint venture of Monsanto and Novozymes representing the largest microbials business in the world at that time. He was most recently chief commercial officer at Compass Minerals, Overland Park, Kan.
“Brad’s industry knowledge, strategic vision, and operational implementation capabilities are a perfect fit to maximize the extensive global commercial opportunities for valuable product creation in agricultural crop protection, animal health and biocontrol that the Renaissance RNA platform technology has application for,” Maurice Boucher, Renaissance’s executive chairman, said in a news release. “Renaissance’s technology addresses the need for environmentally friendly agriculture technologies that are effective and affordable. With the help of experienced senior industry executives like Brad Griffith, we can make major contributions to the future of sustainable agriculture.”
“I am impressed by the innovation capabilities and IP of Renaissance BioScience and their potential to develop next-generation technologies that can help producers maximize economic returns more sustainably,” Griffith said in the release. “I am excited to work with the Renaissance team to bring their technologies to industry. They are very open to partnerships and co-creation.”